Clinical Trials Directory

Trials / Completed

CompletedNCT02464917

Supplemental Oxygen Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
MemorialCare Health System · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare umbilical cord gases in subjects receiving oxygen at 10L/min via simple facemask to subjects receiving room air in those presenting for scheduled cesarean sections.

Detailed description

Objective: To compare umbilical cord gases in subjects receiving oxygen at 10L/min via simple facemask to subjects receiving room air in those presenting for scheduled cesarean sections. The investigators hypothesize that umbilical artery pH levels will not be significantly lowered in the oxygenated group. Primary outcome: umbilical artery pH levels in the oxygenated versus room air group Secondary outcomes: Apgars, respiratory distress syndrome, necrotizing enterocolitis, interventricular hemorrhage, intubation, number of NICU days and neonatal mortality. Methods: Only term elective c-sections will be approached for study consent. Once enrolled subjects will be randomized either receive 10L/min via simple facemask or to room air. Once regional anesthesia is completed, then the facemask with oxygen will be placed. The time from oxygen administration to uterine incision will be at least 10 min. At the time of delivery umbilical cord gases will be collected by and will be processed within one hour of delivery. Inclusion criteria: * 18 years or older * Scheduled cesarean section * Singleton * Term gestation; at 37 0/7 weeks gestation or greater Exclusion criteria: * Maternal lung disease including asthma * Evidence of hypoxemia prior to enrollment * Intrauterine growth restriction * Chronic hypertension * Preeclampsia * Fetal anomalies * Breech position * Multiple Gestation Statistical analysis: Subjects will be randomized via block randomization. The estimated umbilical arterial pH in the scheduled cesarean section room air group is 7.31. To identify a 0.05 or greater difference between the control and treatment group, a power of 0.8, alpha of 0.05 the investigators would need 64 subjects total. To account for drop out the investigators intend to enroll a total of 70 subjects.

Conditions

Interventions

TypeNameDescription
DEVICEDevice: simple facemask to administer supplemental oxygen

Timeline

Start date
2015-06-01
Primary completion
2015-10-01
Completion
2015-11-01
First posted
2015-06-08
Last updated
2019-08-22
Results posted
2019-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02464917. Inclusion in this directory is not an endorsement.